ci 988 has been researched along with formaldehyde in 1 studies
Studies (ci 988) | Trials (ci 988) | Recent Studies (post-2010) (ci 988) | Studies (formaldehyde) | Trials (formaldehyde) | Recent Studies (post-2010) (formaldehyde) |
---|---|---|---|---|---|
147 | 8 | 14 | 22,546 | 243 | 5,887 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blommaert, A; FourniƩ-Zaluski, MC; Noble, F; Roques, BP | 1 |
1 other study(ies) available for ci 988 and formaldehyde
Article | Year |
---|---|
A selective CCKB receptor antagonist potentiates, mu-, but not delta-opioid receptor-mediated antinociception in the formalin test.
Topics: Analgesics; Animals; Disulfides; Enkephalins; Formaldehyde; Indoles; Male; Meglumine; Mice; Morphine; Naloxone; Naltrexone; Pain Measurement; Phenylalanine; Receptors, Cholecystokinin; Receptors, Opioid, delta; Receptors, Opioid, mu | 1995 |